30 related articles for article (PubMed ID: 38636129)
1. Design, Synthesis, and
Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
[TBL] [Abstract][Full Text] [Related]
2. Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors.
Ma Y; Wang T; Cheng L; Ma X; Li R; Zhang M; Chen J; Zhao P
Bioorg Med Chem Lett; 2024 Aug; 108():129816. PubMed ID: 38806101
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and Pro-Apoptotic Activity and Tubulin Dynamics Modulation of 1
Yancheva D; Argirova M; Georgieva I; Milanova V; Guncheva M; Rangelov M; Todorova N; Tzoneva R
Molecules; 2024 May; 29(10):. PubMed ID: 38792260
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis of combretastatin A-4 piperazine derivatives as potential antitumor agents by inhibiting tubulin polymerization and inducing autophagy in HCT116 cells.
Zhang H; Li M; Zhou X; Tang L; Chen G; Zhang Y
Eur J Med Chem; 2024 Jun; 272():116497. PubMed ID: 38759453
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of bimetallic Ag@ZnO nanocomposite and its anti-cancer activity on cervical cancer via impeding PI3K/AKT/mTOR pathway.
Yin Q; Zhou Q; Hu J; Weng J; Liu S; Yin L; Long L; Tong Y; Tang K; Bai S; Ou L
J Trace Elem Med Biol; 2024 Jul; 84():127437. PubMed ID: 38564977
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment.
Abdel-Motaal M; Aldakhili DA; Abo Elmaaty A; Sharaky M; Mourad MAE; Alzahrani AYA; Mohamed NA; Al-Karmalawy AA
Drug Dev Res; 2024 Jun; 85(4):e22197. PubMed ID: 38751223
[TBL] [Abstract][Full Text] [Related]
7. Biological impact and therapeutic potential of a novel camptothecin derivative (FLQY2) in pancreatic cancer through inactivation of the PDK1/AKT/mTOR pathway.
Wang W; Xiong H; Li L; Hu X; Zhuang W; Li J; Sun X; Yu Y; Yu Y; Guo Y; Wang Y; Wang R; Wang H; Li Q
Bioorg Chem; 2024 Jul; 148():107436. PubMed ID: 38735265
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship study of new carbazole sulfonamide derivatives as anticancer agents with dual-target mechanism.
Liu Y; Zhang J; Tian J; Wang C; Wang T; Gong J; Hu L
Eur J Med Chem; 2024 Jul; 273():116509. PubMed ID: 38781920
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel tubulin-targeting agents with a dual-mechanism for polymerization inhibition and protein degradation.
Wang S; Wang J; Lu X; Liu M; Liu Y; Li M; Kong X; Wu L; Guan Q; Zhang W
Eur J Med Chem; 2024 Jun; 272():116458. PubMed ID: 38703557
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives.
Yang Z; Wang Y; Ablise M; Maimaiti A; Mutalipu Z; Yan T; Liu ZY; Aihaiti A
Bioorg Chem; 2024 Aug; 149():107498. PubMed ID: 38805911
[TBL] [Abstract][Full Text] [Related]
11. Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas.
Barreca M; Spanò V; Rocca R; Bivacqua R; Gualtieri G; Raimondi MV; Gaudio E; Bortolozzi R; Manfreda L; Bai R; Montalbano A; Alcaro S; Hamel E; Bertoni F; Viola G; Barraja P
Eur J Med Chem; 2023 Jun; 254():115372. PubMed ID: 37068384
[TBL] [Abstract][Full Text] [Related]
12. Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential.
Tilekar K; Upadhyay N; Hess JD; Macias LH; Mrowka P; Aguilera RJ; Meyer-Almes FJ; Iancu CV; Choe JY; Ramaa CS
Eur J Med Chem; 2020 Sep; 202():112603. PubMed ID: 32634629
[TBL] [Abstract][Full Text] [Related]
13. Environmentally friendly and efficient TBHP-mediated catalytic reaction for the synthesis of substituted benzimidazole-2-ones: In-silico approach to pharmaceutical applications.
Indira M; Surendranath Reddy EC; Kamala Prasad V; Satyanarayana Swamy V; Kakarla RR; Venkata Krishna Reddy M; Attiri P; Vasu Govardhana Reddy P; Aminabhavi TM
Environ Res; 2024 Jul; 252(Pt 1):118760. PubMed ID: 38522741
[TBL] [Abstract][Full Text] [Related]
14. Non-peptidic substrate-mimetic inhibitors of Akt as potential anti-cancer agents.
Kayser-Bricker KJ; Glenn MP; Lee SH; Sebti SM; Cheng JQ; Hamilton AD
Bioorg Med Chem; 2009 Feb; 17(4):1764-71. PubMed ID: 19179081
[TBL] [Abstract][Full Text] [Related]
15. First total synthesis, antitumor evaluation and target identification of mornaphthoate E: A new tubulin inhibitor template acting on PI3K/Akt signaling pathway.
Shan P; Ye T; Tang YD; Song H; Wang C; Zhu K; Yang F; Zhang SL; Su PW; Gao S; Zhang H
Acta Pharm Sin B; 2024 May; 14(5):2177-2193. PubMed ID: 38799630
[TBL] [Abstract][Full Text] [Related]
16. Novel Hsp90-Targeting PROTACs: Enhanced synergy with cisplatin in combination therapy of cervical cancer.
Liang J; Wang D; Zhao Y; Wu Y; Liu X; Xin L; Dai J; Ren H; Zhou HB; Cai H; Dong C
Eur J Med Chem; 2024 Jun; 275():116572. PubMed ID: 38861809
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition.
Li SS; Chen JJ; Zhang MM; Wang WX; Zhang WY; Ma C
Eur J Med Chem; 2024 May; 271():116425. PubMed ID: 38636129
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel pyrazinone derivatives as PI3K/HDAC dual inhibitors.
Wang ZX; Wang S; Qiao XP; Li WB; Shi JT; Wang YR; Chen SW
Bioorg Med Chem; 2022 Nov; 74():117067. PubMed ID: 36272186
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
